Yinglan (Linda) Shu, Ph.D., is the Director and Head of China Healthcare Research at HSBC. They have extensive experience as a Healthcare Analyst in the financial services industry, having previously served as the Executive Director and Leading Analyst at Haitong International Securities Group Limited. Yinglan holds a Ph.D. in Biomedical Sciences from The Chinese University of Hong Kong and a Bachelor of Science in Pharmaceutical Sciences from Peking University. They are skilled in biotech analysis, financial modeling, and SPSS.
This person is not in the org chart
This person is not in any teams
This person is not in any offices